choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Xenical

Xenical Newsletter
  • Best Weight Loss Medication in 2025 28 Mar 2025 19:52 GMT

    trials show it may help you lose more weight than other drugs … ) Weight Loss Medications Orlistat (Alli, Xenical) Orlistat helps … any medication. A doctor can recommend the best treatment based … Regulatory Status Only FDA-approved medications should be used …

  • WEGOVY Marks Significant Growth in Market Share Across the 7MM for Obesity Treatment | DelveInsight 27 Feb 2025 18:00 GMT

    … Phase III trials to assess … medications include CONTRAVE (naltrexone-bupropion), SAXENDA (liraglutide), XENICALmedications as a chronic disease treatment rather than a lifestyle drug … , including Daewoong Pharmaceutical, Janssen Biotech, Zealand Pharma, …

  • Gold outperforms common weight loss drugs – and leaves muscles alone 11 Feb 2025 15:28 GMT

    … control (no treatment) and existing weight-loss drug orlistat (brand name Xenical). The … forget that there are other medications out there, such as orlistat … therapy and in drug delivery, but a human obesity trial remains elusive …

  • Anti-Obesity Drugs Market to Expand from USD 4.6 Billion in 2023 to USD 39.3 Billion by 2033 06 Feb 2025 07:52 GMT

    … in Trials: AI predicts drug trialtrial data collection. •Personalized Treatments: AI customizes obesity treatments … and biotechnology facilitate the … medications. The presence of major pharmaceutical companies ensures easy access to innovative drugs

  • Determining the Correlation Between Obesity Management Drug Dispensed Prescriptions and Online Search Behavior 31 Jan 2025 04:39 GMT

    treatments of a healthy diet and exercise, the pharmaceutical … clinical trials have been demonstrating that this drug … Alli (GlaxoSmithKline), Orlistat (generic), Xenical (Roche)], phentermine [Lomaira ( … shift in obesity medication patterns, with semaglutide …

  • What is Fatty Liver Disease? Prevention and Treatment Options 16 Jan 2025 08:51 GMT

    … , HOD & Consultant, Medical Gastroenterology, Manipal Hospital, Baner, … These include medications like ● Rezdiffra: a new pill that should … as well. ● Orlistat (Xenical): a tablet that helps … Also, Doctors must be consulted for advice and treatment options …

  • New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs 26 Nov 2024 21:27 GMT

    … efficacy throughout numerous randomized controlled trials (RCTs) over the years, … AOMs FDA-approved for long-term use: liraglutide (Saxenda), orlistat (Xenical, … ;upshot/obesity-drugs-medicare-medicaid.html 2. Medicare and Medicaid Programs: Contract Year …

  • GLP-1s Are At the Forefront, but Other Obesity Treatments Exist 07 Nov 2024 20:25 GMT

    Treatment and Medications Potentially Eradicate Diabetes Efficiently (STAMPEDE) trial … ) Receptor Agonists Clinical trials of semaglutide (Wegovy … Xenical; Chepla Pharm, H2-Pharma) is an overall very safe medication … interfere with drug and vitamin absorption …

  • Sex, race, insurance type predict youth access to obesity drugs 05 Nov 2024 13:28 GMT

    … associated with likelihood of obesity drug prescription among youths, including female … of potential predictors of medication prescription for obesity treatment in youth aged … , KVK-Tech), 0.54% orlistat (Xenical, Roche), 79.24% metformin and …

  • What are the best prescription weight loss pills? 30 Oct 2024 16:41 GMT

    … ) Orlistat (brand names Xenical, Alli) Phentermine (brand … start treatment (a known side effect of antidepressants).  … clinical trials.  These FDA-approved weight loss pills mainly … drugs in the FDA-approved weight loss medicine Contrave, is an antidepressant

Satisfied with the content?

Continue to create your account.